Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|December 13, 2003
[Antiepileptic primidone shortly to be withdrawn from sale: change medication now]G J de Haan, J A Carpay, C A van DonselaarJournal of Neurology|May 1, 1987
Successful treatment of acute subdural haematoma associated with severe bleeding disorderP Verlooy, B J Lamers, G J de Haan, et al.Nederlands Tijdschrift Voor Geneeskunde|June 1, 2002
[From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene]G J de Haan, D J J Halley, W H Deelen, et al.Epilepsy & Behavior : E&B|May 9, 2013
Hyperactive behavior in a family with autosomal dominant lateral temporal lobe epilepsy caused by a mutation in the LGI1/epitempin geneB Berghuis, E H Brilstra, D Lindhout, et al.Acta Neurologica Scandinavica|June 20, 2017
Electro-clinical criteria and surgical outcome: Is there a difference between mesial and lesional temporal lobe epilepsy?M Wassenaar, F S S Leijten, G-J de Haan, et al.Neurology|August 12, 2004
Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy studyG-J de Haan, P Edelbroek, J Segers, et al.CNS Drugs|April 17, 2003
Selection criteria for the clinical use of the newer antiepileptic drugsCharles L P Deckers, P D Knoester, G J de Haan, et al.Epilepsia|November 20, 1998
Influence of an evacuation in February 1995 in The Netherlands on the seizure frequency in patients with epilepsy: a controlled studyW A Swinkels, M Engelsman, D G Kasteleijn-Nolst Trenité, et al.Electroencephalography and Clinical Neurophysiology|August 1, 1994
Motor nerve refractory period distribution assessed by two techniques in diabetic polyneuropathyM W Ruijten, G J De Haan, R P Michels, et al.European Journal of Neurology|June 24, 2016
Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremiaB Berghuis, G-J de Haan, M P H van den Broek, et al.Pageof 2